Business Description
Pet Pharm Biotech Co Ltd
ISIN : TW0007762007
Total Employee Number:
44Description
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.75 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | 1.83 | |||||
Interest Coverage | 16.55 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 12.19 | |||||
Beneish M-Score | 0.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.4 | |||||
3-Year EBITDA Growth Rate | 38.1 | |||||
3-Year Book Growth Rate | 86 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.36 | |||||
9-Day RSI | 45.9 | |||||
14-Day RSI | 46.61 | |||||
3-1 Month Momentum % | 2.42 | |||||
6-1 Month Momentum % | -27.47 | |||||
12-1 Month Momentum % | -12.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.68 | |||||
Quick Ratio | 10.42 | |||||
Cash Ratio | 9.22 | |||||
Days Inventory | 43.28 | |||||
Days Sales Outstanding | 73.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.5 | |||||
Dividend Payout Ratio | 0.19 | |||||
Forward Dividend Yield % | 0.5 | |||||
5-Year Yield-on-Cost % | 0.18 | |||||
3-Year Average Share Buyback Ratio | -10.7 | |||||
Shareholder Yield % | -19.18 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.44 | |||||
Operating Margin % | 6.65 | |||||
Net Margin % | 11.25 | |||||
EBITDA Margin % | 26.87 | |||||
FCF Margin % | 1.99 | |||||
OCF Margin % | 15.45 | |||||
ROE % | 2.83 | |||||
ROA % | 2.33 | |||||
ROIC % | 2.43 | |||||
3-Year ROIIC % | 2.73 | |||||
ROC (Joel Greenblatt) % | 6.71 | |||||
ROCE % | 2.62 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 109.58 | |||||
PE Ratio without NRI | 109.58 | |||||
PS Ratio | 12.43 | |||||
PB Ratio | 2.46 | |||||
Price-to-Tangible-Book | 2.67 | |||||
Price-to-Operating-Cash-Flow | 80.63 | |||||
EV-to-EBIT | 99.82 | |||||
EV-to-EBITDA | 41.95 | |||||
EV-to-Revenue | 11.27 | |||||
EV-to-FCF | 566.21 | |||||
Price-to-Graham-Number | 3.61 | |||||
| Price-to-Net-Current-Asset-Value | 6.76 | |||||
| Price-to-Net-Cash | 8.36 | |||||
Earnings Yield (Greenblatt) % | 1 | |||||
FCF Yield % | 0.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pet Pharm Biotech Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 222.032 | ||
| EPS (TTM) (NT$) | 0.454 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 46.72 | ||
| 14-Day RSI | 46.61 | ||
| 14-Day ATR (NT$) | 1.820746 | ||
| 20-Day SMA (NT$) | 50.36681 | ||
| 12-1 Month Momentum % | -12.91 | ||
| 52-Week Range (NT$) | 46.157635 - 89.852216 | ||
| Shares Outstanding (Mil) | 58.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pet Pharm Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pet Pharm Biotech Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.250000 Cash Dividend | 2026-07-20 | 49.16 (-0.20%) | ||
| 1.015:1 Stock Split | 2026-07-20 | 49.16 (-0.20%) | ||
| TWD 0.088150 Cash Dividend | 2025-08-25 | 70.77 (+0.00%) | ||
| 1.01342:1 Stock Split | 2025-08-25 | 70.77 (+0.00%) | ||
| TWD 0.187844 Cash Dividend | 2024-08-22 | 35.99 (+7.19%) |
Show
Entries
Pet Pharm Biotech Co Ltd Frequently Asked Questions
What is Pet Pharm Biotech Co Ltd(ROCO:7762)'s stock price today?
The current price of ROCO:7762 is NT$49.75. The 52 week high of ROCO:7762 is NT$89.85 and 52 week low is NT$46.16.
When is next earnings date of Pet Pharm Biotech Co Ltd(ROCO:7762)?
The next earnings date of Pet Pharm Biotech Co Ltd(ROCO:7762) is .
Does Pet Pharm Biotech Co Ltd(ROCO:7762) pay dividends? If so, how much?
The Dividend Yield %  of Pet Pharm Biotech Co Ltd(ROCO:7762) is 0.5% (As of Today), Highest Dividend Payout Ratio of Pet Pharm Biotech Co Ltd(ROCO:7762) was 0.53. The lowest was 0.19. And the median was 0.36. The  Forward Dividend Yield % of Pet Pharm Biotech Co Ltd(ROCO:7762) is 0.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pet Pharm Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers